InvestorsObserver
×
News Home

Should Biotechnology Stock Savara Inc (SVRA) Be in Your Portfolio Monday?

Monday, August 21, 2023 02:01 PM | InvestorsObserver Analysts

Mentioned in this article

Should Biotechnology Stock Savara Inc (SVRA) Be in Your Portfolio Monday?

Savara Inc (SVRA) is near the top in its industry group according to InvestorsObserver. SVRA gets an overall rating of 84. That means it scores higher than 84 percent of stocks. Savara Inc gets a 99 rank in the Biotechnology industry. Biotechnology is number 64 out of 148 industries.

Overall Score - 84
SVRA has an Overall Score of 84. Find out what this means to you and get the rest of the rankings on SVRA!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 84 would rank higher than 84 percent of all stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Savara Inc Stock Today?

Savara Inc (SVRA) stock is trading at $3.76 as of 1:53 PM on Monday, Aug 21, a rise of $0.22, or 6.21% from the previous closing price of $3.54. The stock has traded between $3.54 and $3.78 so far today. Volume today is light. So far 214,889 shares have traded compared to average volume of 520,339 shares. Click Here to get the full Stock Report for Savara Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App